| DANAHER CORP. DL-,01 |
| USA |
| Gesundheit |
| US2358511028 / 866197 |
| DAP (Frankfurt) / DHR (NYSE) |
| FRA:DAP, ETR:DAP, DAP:GR, NYSE:DHR |
| S&P500 |
| https://www.danaher.com/ |
|
Danaher Corp. is a global science and technology company focused on biotechnology, life sciences, and diagnostics. The company develops and supplies mission-critical tools, consumables, instruments, software, and services used in research, bioprocess..
>Volltext.. |
| 140508.31 Mio. EUR |
| 161075.85 Mio. EUR |
| 22359.87 Mio. EUR |
| 6992.86 Mio. EUR |
| 3565.89 Mio. EUR |
| 5.04 EUR |
| 24809.86 Mio. EUR |
| 3872.25 Mio. EUR |
| 5909.02 Mio. EUR |
| 0.54 |
| 7.85% |
| 21.01% |
| 1.32 EUR |
| 0.68% |
| 0.71% |
| 30.09.26 - 0.35288€ 26.06.26 - 0.35192€ >weitere anzeigen... |
| - |
| DANAHER |
| 21.10.26 |
|
||||
|
||||
|
||||
|